Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy-Reference-Cited by-同舟云学术

Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy

Published:2004-03 Issue:1 Volume:59 Page:35-42
ISSN:0920-1211
Container-title:Epilepsy Research
language:en
Short-container-title:Epilepsy Research

Author:

Coppola Giangennaro,Mangano Salvatore,Tortorella Gaetano,Pelliccia Andrea,Fels Antonio,Romano Angela,Nardello Rosaria,Habetswallner Francesco,Licciardi Felicia,Operto Francesca Felicia,Pascotto Antonio

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference20 articles.

1. Levetiracetam adjunct therapy for refractory pediatric generalised epilepsies;Barron;Epilepsia,2001

2. Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy;Ben-Menachem;Seizure,2003

3. Open-label assessment of levetiracetam efficacy and adverse effects in a pediatric population;Bourgeois;Epilepsia,2001

4. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial;Cereghino;Neurology,2000

5. Commission on classification and terminology of the International League against Epilepsy, 1981. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22, 489–501.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modified Atkins diet versus levetiracetam for non-surgical drug-resistant epilepsy in children: A randomized open-label study;Seizure;2022-12

2. Hallucination: A rare complication of levetiracetam theraphy;NORTH CLIN ISTANB;2017

3. Efficacy of Levetiracetam Monotherapy in Childhood Epilepsy;Journal of the Turkish Epilepsi Society;2017

4. A single-blinded phenobarbital-controlled trial of levetiracetam as mono-therapy in dogs with newly diagnosed epilepsy;The Veterinary Journal;2016-02

5. Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures;Expert Opinion on Pharmacotherapy;2014-01-17